Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 5 of 5 entries
View as:
Phase: N/A
Priority: Normal
Start: 12/09/21
End: 01/21/22
Due: 01/21/23
Phase: N/A
Priority: Normal
Start: 03/01/17
End: 05/31/17
Due: 05/31/18
Phase: N/A
Priority: Normal
Start: 11/30/11
End: 06/30/12
Due: 06/30/13
Phase: N/A
Priority: Normal
Start: 01/15/18
End: 08/31/18
Due: 08/31/19
Phase: N/A
Priority: Normal
Start: 10/07/21
End: 10/27/21
Due: 10/27/22
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation | NCT05584176 | MP Biomedicals, LLC | user2@example.com | None | 2021-12-09 | 2022-01-21 | 2023-01-21 | - | - | 2025-07-14 |
| Dual Algorithm Post Market Clinical Study | NCT03146013 | MP Biomedicals, LLC | user2@example.com | None | 2017-03-01 | 2017-05-31 | 2018-05-31 | - | - | 2025-07-14 |
| Evaluation of the MP Diagnostics HTLV Blot 2.4 | NCT01467024 | MP Biomedicals, LLC | user2@example.com | None | 2011-11-30 | 2012-06-30 | 2013-06-30 | - | - | 2025-07-14 |
| MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study | NCT03226119 | MP Biomedicals, LLC | user2@example.com | None | 2018-01-15 | 2018-08-31 | 2019-08-31 | - | - | 2025-07-14 |
| COVID-19 MP Biomedicals Rapid SARS-CoV-2 Antigen Test Usability | NCT05584189 | MP Biomedicals, LLC | user2@example.com | None | 2021-10-07 | 2021-10-27 | 2022-10-27 | - | - | 2025-07-14 |